Sr. Director, Real-world Data Strategy at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Deep expertise in clinical and genomics real-world data
Strong knowledge of the RWD compliance landscape
Expertise in global RWD opportunities both within BMS and externally
Strong orientation to the application of AI innovation to the field

Responsibilities

Develop and execute a global real-world data (RWD) strategy that aligns with BMS's research, translational medicine, and commercial goals
Communicate strategic direction and decisions to internal and external stakeholders, ensuring organizational alignment
Prioritize RWD investments based on business impact and strategic fit, tracking return on investment across functions
Lead, grow, and empower a diverse global team of data strategists, scientists, and engineers
Build and nurture collaborative relationships with internal stakeholders and external partners to expand RWD capabilities and foster innovation
Identify opportunities for new partnerships and cultivate connections that drive data acquisition and solution development
Oversee acquisition, integration, and enablement of RWD assets to support research, development, and regulatory needs. Ensure fit-for-purpose data selection and avoid redundant purchases
Implement robust data quality frameworks and standards, driving automation and harmonization across datasets and functions
Ensure strict adherence to global compliance, privacy regulations, and ethical standards in all RWD activities
Champion the application of AI, advanced analytics, and emerging technologies to unlock new insights and capabilities from RWD
Deliver regulatory-grade RWD packages when needed (e.g., external control arms, label expansion)
Partner with cross-functional teams in biostatistics, epidemiology, and data science to ensure access to impactful data and support clinical and commercial use cases
Facilitate centralized access to RWD for teams across Commercial, Medical, and R&D, enhancing usability and impact
Provide training, guidance, and tools to democratize RWD use and empower teams to leverage data effectively
Support key use cases such as medical studies, trial feasibility, external control arms, and post-marketing commitments
Continuously measure and communicate the value of RWD investments using clear KPIs, dashboards, and case studies
Monitor business impact, including improved trial timelines

Skills

Real-World Data

RWD Strategy

Genomics

Clinical Data

Data Science

Translational Medicine

Strategic Leadership

RWD Compliance

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free